Ocade D Capsule is a combination pharmaceutical formulation containing Domperidone 10 mg and Omeprazole 20 mg, designed to manage gastrointestinal disorders characterized by acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, effectively reducing gastric acidity and promoting mucosal healing. The synergistic action of these agents makes Ocade D Capsule particularly effective in treating conditions such as gastroesophageal reflux disease (GERD), dyspepsia, and peptic ulcer disease, where both acid suppression and improved gastric motility are required. It is indicated for patients experiencing heartburn, acid regurgitation, and delayed gastric emptying symptoms. Ocade D Capsule should be administered as prescribed by a healthcare professional, considering contraindications such as hypersensitivity to components, and used cautiously in patients with underlying cardiac conditions. Adherence to dosage instructions and monitoring for potential side effects, including headache, dry mouth, or gastrointestinal disturbances, is recommended for optimal therapeutic outcomes.